Todd Colonna, MD
Dermatology · Rockville, MDNPI 1306826102
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $14,254 of the $17,298 with a category attached, or 82.4%. It is spread thinly across 38 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $5,132 and has fallen 69.6% since, to $1,559 in 2025.
Across 783 payments — averaging $22.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dermavant Sciences, Inc.$3K
- Johnson & Johnson$2K
- Novartis$2K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
- Pfizer$1K
- Lilly USA, LLC$885
- plus $8K from 32 others
What the payments were for
- Consulting fees$2,00012%
- Speaking & faculty fees$3502%
- Food & beverage$14,25482%
- Education$6944%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dermavant Sciences, Inc. | 61 | $3,189 |
| Johnson & Johnson | 66 | $1,844 |
| Novartis | 100 | $1,588 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 67 | $1,111 |
| Pfizer | 56 | $1,072 |
| Lilly USA, LLC | 39 | $885 |
| Galderma Laboratories, L.p. | 38 | $746 |
| Sanofi | 14 | $716 |
| Mayne Pharma Commercial LLC | 59 | $683 |
| UCB, Inc. | 27 | $590 |
| AbbVie | 34 | $572 |
| Sun Pharmaceutical Industries Inc. | 28 | $484 |
| Incyte Corporation | 22 | $483 |
| Boehringer Ingelheim | 18 | $479 |
| Amgen | 26 | $471 |
| E.r. Squibb & Sons, L.L.C. | 26 | $439 |
| Arcutis Biotherapeutics, Inc. | 18 | $328 |
| LEO Pharma Inc. | 11 | $233 |
| Regeneron Healthcare Solutions, Inc. | 7 | $205 |
| VYNE Pharmaceuticals Inc. | 10 | $182 |
| Organon | 12 | $174 |
| Bristol Myers Squibb | 6 | $130 |
| Dermira, Inc. | 6 | $106 |
| Journey Medical Corporation | 4 | $90 |
| EPI Health, LLC | 4 | $71 |
| Encore Dermatology Inc. | 4 | $70 |
| Taro Pharmaceuticals USA, Inc. | 3 | $56 |
| Almirall LLC | 3 | $54 |
| Lumenis, Inc | 1 | $47 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Botanix SB Inc | 2 | $40 |
| Sebela Pharmaceuticals Inc. | 2 | $28 |
| Promius Pharma LLC | 1 | $22 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Biofrontera Inc. | 2 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,298 in reported general payments places this provider in the 85th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 174 | $11,224 |
| Pimecrolimus | 14 | $4,699 |
| Adapalene-Benzoyl PeroxideAdapalene/Benzoyl Peroxide | 14 | $3,082 |
| Fluocinonide | 47 | $2,698 |
| Mometasone Furoate | 101 | $2,397 |
| Desoximetasone | 21 | $2,294 |
| Doxycycline Hyclate | 117 | $2,074 |
| Triamcinolone Acetonide | 185 | $1,813 |
| Metronidazole | 22 | $1,028 |
| Tacrolimus | 11 | $953 |
| Econazole Nitrate | 49 | $903 |
| Betamethasone Valerate | 21 | $825 |
| Fluticasone Propionate | 21 | $638 |
| Clindamycin Phosphate | 18 | $412 |
| CiclopiroxCiclopirox Olamine | 40 | $388 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rockville
- Ronald ShoreRockville$105K
- Jay BarnettRockville$13K
- Benjamin LockshinSilver Spring$4M
- Shawn KwatraBaltimore$1.1M
- Chesahna Kindred WeaverMarriottsville$837K
- Oanh LauringNottingham$763K
- Ronald PrussickN Bethesda$620K
- Rebecca KazinChevy Chase$342K
- Susan WalkerBethesda$221K
- Monte MeltzerBerlin$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.